Lymphotoxin-α Gene and Risk of Myocardial Infarction in 6,928 Cases and 2,712 Controls in the ISIS Case-Control Study

• Robert Clarke ,

  Contributed equally to this work with: Robert Clarke, Peng Xu

  *To whom correspondence should be addressed. E-mail: robert.clarke@ctsu.ox.ac.uk

  Affiliation Clinical Trial Service Unit, Old Road Campus, Oxford, United Kingdom

  ⨯
• Peng Xu ,

  Contributed equally to this work with: Robert Clarke, Peng Xu

  Affiliation Centre National de Genotypage, Paris, France

  ⨯
• Derrick Bennett,

  Affiliation Clinical Trial Service Unit, Old Road Campus, Oxford, United Kingdom

  ⨯
• Sarah Lewington,

  Affiliation Clinical Trial Service Unit, Old Road Campus, Oxford, United Kingdom

  ⨯
• Krina Zondervan,

  Affiliation Wellcome Trust Centre for Human Genetics, Old Road Campus, Oxford, United Kingdom

  ⨯
• Sarah Parish,

  Affiliation Clinical Trial Service Unit, Old Road Campus, Oxford, United Kingdom

  ⨯
• Alison Palmer,

  Affiliation Clinical Trial Service Unit, Old Road Campus, Oxford, United Kingdom

  ⨯
• Sarah Clark,

  Affiliation Clinical Trial Service Unit, Old Road Campus, Oxford, United Kingdom

  ⨯
• Lon Cardon,

  Affiliation Wellcome Trust Centre for Human Genetics, Old Road Campus, Oxford, United Kingdom

  ⨯
• Richard Peto,

  Affiliation Clinical Trial Service Unit, Old Road Campus, Oxford, United Kingdom

  ⨯
• Mark Lathrop,

  Affiliation Centre National de Genotypage, Paris, France

  ⨯
• Rory Collins, for the International Study of Infarct Survival (ISIS) Collaborators

  Affiliation Clinical Trial Service Unit, Old Road Campus, Oxford, United Kingdom

  ⨯